“People who experience SRED are at an increased risk of fatigue, depression and weight gain,” Johnston said. They’re also at ...

More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...

Notably, Zepbound's main rival, the weight loss drug Wegovy from Novo Nordisk, is not approved for OSA. Zepbound could be a ...

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

Snoring can be a sign of hypothyroidism, as low thyroid hormone levels may weaken respiratory muscles, contributing to airway ...

Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

Patients in both treatment groups had significantly reduced mean pain scores and experienced less pain while sleeping. The percentage of patients receiving the flexible-dosage regimen who ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Occasional daytime sleepiness that can be traced back to ... Medications are the first-line treatment for idiopathic hypersomnia, but some people may also benefit from improved sleep hygiene ...